These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 28551021)

  • 21. Chromatography process development in the quality by design paradigm I: Establishing a high-throughput process development platform as a tool for estimating "characterization space" for an ion exchange chromatography step.
    Bhambure R; Rathore AS
    Biotechnol Prog; 2013; 29(2):403-14. PubMed ID: 23424083
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A new large-scale manufacturing platform for complex biopharmaceuticals.
    Vogel JH; Nguyen H; Giovannini R; Ignowski J; Garger S; Salgotra A; Tom J
    Biotechnol Bioeng; 2012 Dec; 109(12):3049-58. PubMed ID: 22688835
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Keeping pace with the increasing demand for high quality drug candidates in pharmaceutical research: Development of a new two-step preparative tandem high performance chromatographic system for the purification of antibodies.
    Schmitz S; Schönfeld DL; Freitag B; Götzberger-Schad C; Fischer M; Linden L
    J Chromatogr B Analyt Technol Biomed Life Sci; 2019 Jan; 1104():18-28. PubMed ID: 30423523
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Exploring the linkage between cell culture process parameters and downstream processing utilizing a plackett-burman design for a model monoclonal antibody.
    Agarabi CD; Chavez BK; Lute SC; Read EK; Rogstad S; Awotwe-Otoo D; Brown MR; Boyne MT; Brorson KA
    Biotechnol Prog; 2017 Jan; 33(1):163-170. PubMed ID: 27813291
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A tandem laboratory scale protein purification process using Protein A affinity and anion exchange chromatography operated in a weak partitioning mode.
    Shamashkin M; Godavarti R; Iskra T; Coffman J
    Biotechnol Bioeng; 2013 Oct; 110(10):2655-63. PubMed ID: 23633385
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Integrated continuous production of recombinant therapeutic proteins.
    Warikoo V; Godawat R; Brower K; Jain S; Cummings D; Simons E; Johnson T; Walther J; Yu M; Wright B; McLarty J; Karey KP; Hwang C; Zhou W; Riske F; Konstantinov K
    Biotechnol Bioeng; 2012 Dec; 109(12):3018-29. PubMed ID: 22729761
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Traces matter: Targeted optimization of monoclonal antibody N-glycosylation based on/by implementing automated high-throughput trace element screening.
    Markert S; Torkler S; Hohmann K; Popp O
    Biotechnol Prog; 2020 Nov; 36(6):e3042. PubMed ID: 32583628
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Very large scale monoclonal antibody purification: the case for conventional unit operations.
    Kelley B
    Biotechnol Prog; 2007; 23(5):995-1008. PubMed ID: 17887772
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Development of at-line assay to monitor charge variants of MAbs during production.
    St Amand MM; Ogunnaike BA; Robinson AS
    Biotechnol Prog; 2014; 30(1):249-55. PubMed ID: 24382831
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Chemometrics applications in biotechnology processes: predicting column integrity and impurity clearance during reuse of chromatography resin.
    Rathore AS; Mittal S; Lute S; Brorson K
    Biotechnol Prog; 2012; 28(5):1308-14. PubMed ID: 22888107
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Conversion of a CHO cell culture process from perfusion to fed-batch technology without altering product quality.
    Meuwly F; Weber U; Ziegler T; Gervais A; Mastrangeli R; Crisci C; Rossi M; Bernard A; von Stockar U; Kadouri A
    J Biotechnol; 2006 May; 123(1):106-16. PubMed ID: 16324762
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Technological progresses in monoclonal antibody production systems.
    Rodrigues ME; Costa AR; Henriques M; Azeredo J; Oliveira R
    Biotechnol Prog; 2010; 26(2):332-51. PubMed ID: 20043321
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Characterization of TAP Ambr 250 disposable bioreactors, as a reliable scale-down model for biologics process development.
    Xu P; Clark C; Ryder T; Sparks C; Zhou J; Wang M; Russell R; Scott C
    Biotechnol Prog; 2017 Mar; 33(2):478-489. PubMed ID: 27977912
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Development toward rapid and efficient screening for high performance hydrolysate lots in a recombinant monoclonal antibody manufacturing process.
    Luo Y; Pierce KM
    Biotechnol Prog; 2012 Jul; 28(4):1061-8. PubMed ID: 22641483
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Single pass diafiltration integrated into a fully continuous mAb purification process.
    Rucker-Pezzini J; Arnold L; Hill-Byrne K; Sharp T; Avazhanskiy M; Forespring C
    Biotechnol Bioeng; 2018 Aug; 115(8):1949-1957. PubMed ID: 29663323
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Reduction of product-related species during the fermentation and purification of a recombinant IL-1 receptor antagonist at the laboratory and pilot scale.
    Schirmer EB; Golden K; Xu J; Milling J; Murillo A; Lowden P; Mulagapati S; Hou J; Kovalchin JT; Masci A; Collins K; Zarbis-Papastoitsis G
    Biotechnol J; 2013 Aug; 8(8):946-56. PubMed ID: 23913906
    [TBL] [Abstract][Full Text] [Related]  

  • 37. High-throughput micro-scale cultivations and chromatography modeling: Powerful tools for integrated process development.
    Baumann P; Hahn T; Hubbuch J
    Biotechnol Bioeng; 2015 Oct; 112(10):2123-33. PubMed ID: 25988478
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Novel micro-bioreactor high throughput technology for cell culture process development: Reproducibility and scalability assessment of fed-batch CHO cultures.
    Amanullah A; Otero JM; Mikola M; Hsu A; Zhang J; Aunins J; Schreyer HB; Hope JA; Russo AP
    Biotechnol Bioeng; 2010 May; 106(1):57-67. PubMed ID: 20073088
    [TBL] [Abstract][Full Text] [Related]  

  • 39. High-throughput methods for miniaturization and automation of monoclonal antibody purification processes.
    Treier K; Hansen S; Richter C; Diederich P; Hubbuch J; Lester P
    Biotechnol Prog; 2012; 28(3):723-32. PubMed ID: 22467605
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Process-scale purification from cell culture supernatants: monoclonal antibodies.
    Ostlund C; Borwell P; Malm B
    Dev Biol Stand; 1987; 66():367-75. PubMed ID: 3108053
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.